Table 1. Characteristics of Option B+ patients (Categorical variables).
| Option B+ | Attritionǂ | p-valueǁ | |||
|---|---|---|---|---|---|
| n | % | n | % | ||
| Total | 2,166 | 100.0% | 1,023 | 47.2% | |
| Marital status | |||||
| Married/concubinage | 1,425 | 65.8% | 683 | 66.8% | 0.67 |
| Widow/divorce | 90 | 4.2% | 38 | 3.7% | |
| Single | 236 | 10.9% | 107 | 10.5% | |
| Missing/Unknown | 415 | 19.2% | 195 | 19.1% | |
| Location of residence | |||||
| Different commune | 647 | 29.9% | 303 | 29.6% | 0.70 |
| Same commune | 1,470 | 67.9% | 694 | 67.8% | |
| Missing | 49 | 2.3% | 26 | 2.5% | |
| HIV+ household member | |||||
| No | 818 | 37.8% | 363 | 35.5% | <0.001 |
| Yes | 106 | 4.9% | 35 | 3.4% | |
| Missing | 1,242 | 57.3% | 625 | 61.1% | |
| Household size | |||||
| 1–3 members | 698 | 32.2% | 314 | 30.7% | <0.001 |
| >3 members | 226 | 10.4% | 84 | 8.2% | |
| Missing | 1,242 | 57.3% | 625 | 61.1% | |
| WHO stage | |||||
| I | 941 | 43.4% | 468 | 45.7% | <0.001 |
| II | 517 | 23.9% | 231 | 22.6% | |
| III | 369 | 17.0% | 145 | 14.2% | |
| IV | 100 | 4.6% | 44 | 4.3% | |
| Missing | 239 | 11.0% | 135 | 13.2% | |
| Period of ART start | |||||
| Oct12-Mar13 | 893 | 41.2% | 401 | 39.2% | 0.13 |
| Apr13-Sep13 | 1,086 | 50.1% | 536 | 52.4% | |
| Oct13-Mar14 | 187 | 8.6% | 86 | 8.4% | |
| Starting ART regimen | |||||
| AZT-3TC-EFV | 201 | 9.3% | 82 | 8.0% | 0.11 |
| AZT-3TC-NVP | 155 | 7.2% | 80 | 7.8% | |
| TDF-3TC-EFV | 1,752 | 80.9% | 829 | 81.0% | |
| All Other | 58 | 2.7% | 32 | 3.1% | |
| Supportive services at ART start | |||||
| Treatment supporter named | 274 | 12.7% | 102 | 10.0% | <0.001 |
| Counseling before ART start | 273 | 12.6% | 77 | 7.5% | <0.001 |
| Treatment or prophylaxis for opportunistic infections at ART start | |||||
| TB prophylaxis or treatment | 542 | 25.0% | 269 | 26.3% | 0.20 |
| Cotrimoxizole prophylaxis | 1,441 | 66.5% | 646 | 63.1% | <0.01 |
| Pregnancy | |||||
| Dates of pregnancy known* | 968 | 44.7% | 439 | 42.9% | 0.12 |
| Dates of HIV test and pregnancy known | 850 | 39.2% | 389 | 38.0% | 0.27 |
| HIV test after start of pregnancy** | 687 | 80.8% | 350 | 51.0% | <0.001 |
| Registered for HIV care after preg start*** | 792 | 81.8% | 398 | 50.3% | <0.001 |
ǂAttrition by MSPP definition.
ǁp-value for Chi-2 test statistic comparing attrition and non-attrition cases.
*Pregnancy dates were considered to be known when data were available on last menstrual period date, gestational age, estimated delivery date, or actual delivery date.
**Among cases with dates of HIV test and pregnancy known.
***Among cases with dates of pregnancy known.
AZT = Zidovudine; 3TC = Lamivudine; NVP = Nevirapine; TDF = Tenofovir; EFV = Efavirenz.